Follicle-stimulating hormone does not directly regulate bone mass in human beings: evidence from nature

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2211-2216

  Castelo Branco, Camil ^a   León, Milagro ^b   Durán, Magda ^a   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital de las Mujeres Dr Adolfo Carit Eva   (Costa Rica)

Author keywords

bone markers; bone mass; FSH; Gonadotropins; Kallman syndrome; LH; pure gonadal dysgenesia; sex steroids; Turner syndrome

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CREATININE; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; OSTEOCALCIN; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GONADAL DYSGENESIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS GONAD SYSTEM; KALLMANN SYNDROME; OSTEOPOROSIS; PRIORITY JOURNAL; TURNER SYNDROME;

ADOLESCENT; AMENORRHEA; BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADAL DYSGENESIS, 46,XX; HIP; HUMANS; KALLMANN SYNDROME; LUMBAR VERTEBRAE; OSTEOPOROSIS; PROSPECTIVE STUDIES; TURNER SYNDROME; YOUNG ADULT;

EID: 56949095333     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.040     Document Type: Article

References (33)

1. Stepnick L.S. The frequency of bone disease (2004), Office of the US Surgeon General, Washington, DC
2. Castelo-Branco C., Palacios S., Calaf J., Vazquez F., and Lanchares J.L. Available medical choices for the management of menopause. Maturitas 52 Suppl 1 (2005) S61-S70
3. Castelo-Branco C., and Rostro F. Management of menopause. Minerva Ginecol 58 (2006) 137-152
4. Lindsay R. Hormones and bone health in postmenopausal women. Endocrine 24 (2004) 223-230
5. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98 (2001) 13960-13965
6. Srivastava S., Toraldo G., Weitzmann M.N., Cenci S., Ross F.P., and Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276 (2001) 8836-8840
7. Lindberg M.K., Weihua Z., Andersson N., Moverare S., Gao H., Vidal O., et al. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 174 (2002) 167-178
8. Lindberg M.K., Erlandsson M., Alatalo S.L., Windahl S., Andersson G., Halleen J.M., et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. J Endocrinol 171 (2001) 425-433
9. Windahl S.H., Andersson G., and Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 13 (2002) 195-200
10. Yeh J.K., Chen M.M., and Aloia J.F. Ovariectomy-induced high turnover in cortical bone is dependent on pituitary hormone in rats. Bone 18 (1996) 443-450
11. Yeh J.K., Chen M.M., and Aloia J.F. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy. Am J Physiol 273 (1997) E734-E742
12. Sowers M.R., Greendale G.A., Bondarenko I., Finkelstein J.S., Cauley J.A., Neer R.M., et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 14 (2003) 191-197
13. Kawai H., Furuhashi M., and Suganuma N. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Arch Gynecol Obstet 269 (2004) 192-195
14. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 82 Suppl 1 (2004) S33-S39
15. Del Rio L., Pons F., Huguet M., Setoain F.J., and Setoain J. Anteroposterior versus lateral bone mineral density of spine assessed by dual X-ray absorptiometry. Eur J Nucl Med 22 (1995) 407-412
16. Castelo-Branco C., Gomez O., Pons F., Martinez de Osaba M.J., Balasch J., and Antonio Vanrsell J. Secreting ovarian tumors may protect women from osteoporosis. Gynecol Oncol 88 (2003) 149-152
17. Castelo-Branco C., Martinez de Osaba M.J., Pons F., and Fortuny A. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use. Metabolism 46 (1997) 437-440
18. Castelo-Branco C., Martinez de Osaba M.J., Martinez S., and Fortuny A. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism. Metabolism 45 (1996) 24-27
19. Abe E., Marians R.C., Yu W., Wu X.B., Ando T., Li Y., et al. TSH is a negative regulator of skeletal remodeling. Cell 115 (2003) 151-162
20. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., et al. FSH directly regulates bone mass. Cell 125 (2006) 247-260
21. Khan A.A., and Syed Z. Bone densitometry in premenopausal women: synthesis and review. J Clin Densitom 7 (2004) 85-92
22. Bainbridge K.E., Sowers M., Lin X., and Harlow S.D. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 15 (2004) 439-446
23. Oh K.W., Rhee E.J., Lee W.Y., Kim S.W., Oh E.S., Baek K.H., et al. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. Clin Endocrinol (Oxf) 61 (2004) 244-249
24. Yasui T., Uemura H., Tomita J., Miyatani Y., Yamada M., Miura M., et al. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women. J Endocrinol Invest 29 (2006) 913-918
25. Perrien D.S., Achenbach S.J., Bledsoe S.E., Walser B., Suva L.J., Khosla S., et al. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91 (2006) 1848-1854
26. Castelo-Branco C., Pons F., Martinez de Osaba M.J., Garrido J., and Fortuny A. Menstrual history as a determinant of current bone density in young hirsute women. Metabolism 45 (1996) 515-518
27. Devleta B., Adem B., and Senada S. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J Bone Miner Metab 22 (2004) 360-364
28. Massin N., Czernichow C., Thibaud E., Kuttenn F., Polak M., and Touraine P. Idiopathic premature ovarian failure in 63 young women. Horm Res 65 (2006) 89-95
29. Klein P., Serje A., and Pezzullo J.C. Premature ovarian failure in women with epilepsy. Epilepsia 42 (2001) 1584-1589
30. Galusca B., Bossu C., Germain N., Kadem M., Frere D., Lafage-Proust M.H., et al. Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling. Osteoporos Int 17 (2006) 888-896
31. Suetomi T., Inai H., Manabe F., Shimazui T., and Akaza H. [A case of Kallman syndrome: usefulness of the aging male's symptoms rating scale for assessment of subjective symptoms]. Hinyokika Kiyo 52 (2006) 661-665
32. Chryssikopoulos A. [Dynamic tests in females with Kallmann syndrome]. Geburtshilfe Frauenheilkd 46 (1986) 48-51
33. del Rio L., Carrascosa A., Pons F., Gusinye M., Yeste D., and Domenech F.M. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res 35 (1994) 362-366